Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
378
NCT03165955
A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients
Phase: Phase 1
Role: Lead Sponsor
Start: May 9, 2017
Completion: Nov 22, 2018
NCT04013217
Evaluate Eribulin ORA in Subjects With Solid Tumors
Start: Jul 29, 2019
Completion: Mar 2, 2022
NCT06835400
Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer
Phase: Phase 3
Start: Sep 30, 2025
Completion: May 31, 2029